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Abstract
Background: Very few studies have been conducted on the seroprevalence of syphilis in Gabon. According to the
World Health Organization, the average seroprevalence of syphilis has declined from 5.5 to 1.1% in Central Africa.
The aim of this study was to test the hypothesis that syphilis decreased in Gabon between 2004 and 2016 and to
identify factors involved in this pattern by testing a large sample of first-time blood donors in the capital Libreville.
Methods: The detection of Treponema pallidum was done using a Rapid Plasma Reagin test (RPR) and confirmed
by an ELISA test using the Biorad Syphilis Total Antibody EIA II kit or BioMerieux Trepanostika TP recombinant.
Assays were performed by dedicated technicians according to manufacturers’ recommendations and following the
laboratory standard operating procedures. Test results were manually transferred into the laboratory Excel files and
hand-written in the laboratory logbook for syphilis testing. Logistic regression was used to assess the impact of
sociodemographic characteristics on syphilis marker seroprevalence in both univariate and multivariable analysis.
Odds ratios (OR) and 95% confidence intervals were calculated.
Results: The seroprevalence of syphilis markers was 8.4% (95% CI = 7.9–8.9) in 2004 and 2.4% (95% CI = 2.1–2.7) in
2016. The difference was significant [OR = 3.78; 95% CI (3.26–4.38); P < 0.001]. The decrease in syphilis
seroprevalence was significant in both women and men and in each age group in univariate analysis. In
multivariable analysis, controlling for all sociodemographic factors, the decrease in syphilis seroprevalence from
2004 to 2016 remained significant (OR = 3.29; 95% CI = 2.88–3.88, P < 0.001). The seroprevalence of syphilis
decreased significantly in men compared to women and young donors compared to donors aged ≥36 years.
Conclusions: This study shows a significant decline in syphilis seroprevalence in first-time blood donors in
Libreville, Gabon. Government actions, including multiple HIV prevention activities, are a likely part of this decline.
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Background
Syphilis is essentially a sexually transmitted disease. It can
also be transmitted by contact with injured mucosa, by
blood transfusion and from pregnant women to their new-
born that could have adverse effects on nearly 80% of
pregnancies [1].
According to the World Health Organization (WHO), 6
million new syphilitic infections are contracted each year
despite the existence of effective preventive and thera-
peutic measures [2]. In sub-Saharan Africa (SSA), syphilis
is widespread in the general population, and its seropreva-
lence in some countries’ blood donors may reach 25% [3].
However, prevalence is highly dependent on the testing al-
gorithm and test quality [4, 5].
In Gabon, from 1979 to 1982, blood transfusion was pro-
vided by a blood bank at the Hospital Center of Libreville.
Since 1986, the National Blood Transfusion Center (NBTC)
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ensures the qualification of blood donations by testing for in-
fectious markers such as human immunodeficiency virus
(HIV), hepatitis B and C (HBV and HCV) and the detection
of antibodies against Treponema pallidum pallidum, the
etiological agent of venereal syphilis, using 3rd-generation
manual ELISA and recently 4th-generation semi-automated
(EVOLIS BioRad) or automated ELISA (Cobas 6000 e601).
Syphilis remains a major public health problem in SSA,
even though averaged seroprevalence appears to have de-
creased in Central Africa from 5.5 to 1%, while in Eastern
and Southern Africa it has increased from 0.3 to 0.9% [6].
Very few recent studies have been conducted on the epi-
demiology of syphilis in Gabon [7, 8]. Previous studies
have shown seroprevalence of 13.3% in Franceville adults
in 1988 [9]; in 1989, 11.4% in pregnant women [10] and
8% in a semi-rural population [11] and 4.6 and 2.1% in
first-time blood donors in 2009 and 2015, respectively [8].
Most of these studies have indicated a downward trend in
the seroprevalence of syphilis in Gabon.
The aim of this study was to test the hypothesis that
syphilis seroprevalence decreased in Gabon between
2004 and 2016 and to identify factors involved in this
pattern by testing a large sample of first-time blood do-
nors in the capital Libreville.
Methods
Study site
Gabon is located in Central Africa, straddling the Equator,
and has an area of 267,667 km2. The bordering countries are
Cameroon in the North; Equatorial Guinea in the
North-West, Republic of Congo in the East and South and
the Atlantic Ocean in the West on 800 km of coast. The
country has a population of 1,811,079 inhabitants, with a
density of 6.8 inhabitants per km2, and a population growth
rate of 3.1%. The Gabonese population is mainly young
(54.6% under 25 years). At present, 87% of the population
lives in urban areas, concentrated on 1.1% of the national
territory (“http://www.ga.pnud.org”). The only NBTC is lo-
cated in the Gabonese capital, Libreville, with a cosmopolitan
population of 703,940 inhabitants [12], comprising just over
one third of the Gabonese population. In addition to the
Libreville standalone NBTC, there are 14 hospital-linked
blood banks located in regional hospitals across the country.
Blood donors
The study was carried out at the NBTC, which oversees all
components of the blood donation chain including collec-
tion, screening for transfusion transmitted infections (TTIs)
and distribution of blood components. Before the comput-
erized record of donors and donations in 2000, few data
were available to study blood-borne pathogens among
blood donors in Gabon. The most complete and reliable
data from Libreville blood centre was from 2004. The ma-
jority of the blood was collected at the NBTC in Libreville.
A few donations were collected in mobile sessions, mostly
in secondary schools but also in universities. In addition, in
a previous tri-annual study between 2009 and 2015, we ob-
served a decrease in the seroprevalence of syphilis in blood
donors [8]. We therefore selected the years 2004 and 2016
to test the hypothesis that the prevalence of syphilis has de-
creased in Gabon.
A retrospective analysis of curated data on blood donors
collected between 2004 and 2016 was conducted. All appar-
ently healthy voluntary non-remunerated donors (VNRD)
and family/replacement donors (FRD) were selected after
responding to a range of questions including medical history.
Individuals aged 15 to 65 years old weighing ≥50 kg were eli-
gible for blood donations. Donors aged 15 years are eligible
for blood donations with the agreement of their parents or
guardians. All candidate donors responded to questions
aimed to exclude at risk donations including individuals who
had jaundice or signs of hepatitis, pregnant women and per-
sons with unsafe sexual behavior during the 6 months prior
to blood donation. Venous blood was collected in the blood
bags following standard aseptic procedures.
Serological analysis
Markers of Treponema pallidum were detected using
Rapid Plasma Reagin test (RPR, Cypress, Diagnostic,
Langdorp, Belgium). All reactive samples were confirmed
in 2004 with Trepanostika TP recombinant (bioMérieux,
France) and in 2016 with syphilis Total antibody EIA II kit
(Bio-Rad, Marnes-la-Coquette, France). The sensitivity
and specificity of Trepanostika TP recombinant were 99.1
and 100%, respectively. Those of syphilis Total antibody
EIA II kit were 99.56 and 100%, according to the manufac-
turers. All samples reactive with both initial and secondary
assays were considered positive.
Statistical analysis
Seroprevalence of syphilis was compared by year, overall
and according to demographic characteristics (gender, age
group, occupation and donor type). Logistic regression
was used to assess the impact of these characteristics on
seroprevalence in both univariate and multivariable ana-
lysis. Odds ratios (OR) and 95% confidence intervals are
presented. Statistical Analysis System software (SAS ver-
sion 9.4, Cary, NC) was used for analysis. P values < 0.05
were considered statistically significant.
Results
Sociodemographic characteristics of blood donors
The study included 20,651 first-time donors; 10,904 in
2004 and 9747 in 2016 and were 75.7% men and 24.3%
women. The mean blood donor age was 29.7 ± 8.1 years.
The majority of donors were family donors (70.6%). Most
donors were in the age group 25–35 years (44.4%); donors
less than 35 years accounted for 75% of the total. There was
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a higher percentage of VNRDs in 2014 than in 2016 (38.9%
versus 18.7%). Police and armed forces and students
accounted for 14.7 and 13.8% of donors, respectively. Socio-
demographic data are presented in Table 1.
Decline in the seroprevalence of syphilis among first-time
blood donors
Seroprevalence of confirmed syphilis markers was 8.4%
(95% CI = 7.9–8.9) in 2004 and 2.4% (95% CI = 2.1–2.7) in
2016. Seroprevalence was nearly four times lower in 2016
compared to 2004 (OR = 3.78; 95%CI = 3.26–4.386; p <
0.001). While the overall prevalence of syphilis markers
was significantly lower in females than in males in 2004
(P < 0.001), the decline observed in 2016 was by a factor
of three in females and of four in males and the difference
between sexes was no longer significant (P = 0.28).
Factors influencing the decline of syphilis seropreva-
lence in blood donors were examined (Table 2). The ob-
served considerable decline was in part related to
demographic factors of the donor population. For
instance, in 2016, the proportion of students was 2.7% in
2004 and 26.1% in 2016. Similarly, the proportion of FRD
was 61.1% in 2004 and increased to 81.3% in 2016. As a
result, the proportion of donors below age 35 years was
9.1% higher in 2016. The dramatic decline of syphilis
prevalence in the police and armed forces suggests selec-
tion or testing in this professional category. This suggests
that part of the observed decrease in syphilis prevalence
was related to population change.
In univariate analysis, the decrease in seroprevalence be-
tween 2004 and 2016 was observed in both males and fe-
males, in all age group categories, and in VNRDs as well
as FRDs. Significant decreases were observed in students,
police and armed forces and others occupation categories.
In 2004, the seroprevalence of syphilis was below 5%
until age 25 years and increased progressively with age,
reaching 22.6% above age 45 years. A decline from 4.7%
in 2004 to 0% in 2016 among blood donors < 18 years was
observed. The reduction in prevalence was by a factor of
four and fivefold in donors aged 25–35 years and 18–24
years but by a factor of just over two in older groups (OR
= 2.73, P < 0.001 and OR = 2.71, P < 0.001) (Table 2).
In 2016 syphilis marker seroprevalence was four times
lower than in 2004 for both VNRD and FRD (OR = 4.42,
95% CI = 3.12, 6.25, P < 0.001 and OR = 3.70, 95% CI =
3.13–4.36, P < 0.001) (Table 2). The difference in sero-
prevalence between donor types was not significant (p =
0.57 for 2004 and p = 0.23 for 2016).
With regard to socio-occupational groups, the most
dramatic decline in seroprevalence of syphilis was ob-
served among students and police and armed forces.
The seroprevalence of syphilis was 4.5 and 5.7 times
lower in 2016 than in 2004 in these two professional
groups, respectively.
A non-significant reduction in the seroprevalence of syph-
ilis was observed in the other socio-professional categories
between 2004 and 2016, in part related to small numbers.
There was a 3.2 times decline in seroprevalence of syph-
ilis markers in the large group of ‘other occupations’.
In multivariable analysis (Table 3), controlling for all
sociodemographic factors, the decrease in syphilis sero-
prevalence from 2004 to 2016 remained significant (OR =
3.29; 95% CI = 2.88–3.88, P < 0.001). Syphilis seropreva-
lence decreased significantly in men compared to women
and young donors compared to donors aged ≥36 years.
For first-time blood donor types and occupation, syphilis
seropositivity was not significantly different between
VNRD and FRD and when comparing all professional cat-
egories, particularly after adjustment for age (Table 3).
Discussion
In this study we showed a significant reduction in the sero-
prevalence of syphilis among first-time blood donors in
Libreville between 2004 and 2016. Syphilis seroprevalence
Table 1 Sociodemographic characteristics of first-time blood
donor in 2004 and 2016
Years
2004 2016 Total
Number of donors 10,904 9747 20,651
Gender N (%)
Female 2773 (25.4) 2239 (23.0) 5012 (24.3)
Male 8131 (74.6) 7508 (77.0) 15,639 (75.7)
Age groups N (%)
<18 years 127 (1.2) 15 (0.2) 142 (0.7)
18–24 years 3114 (28.6) 3042 (31.2) 6156 (29.8)
25–35 years 4463 (40.9) 4713 (48.4) 9176 (44.4)
36–45 years 2404 (22.0) 1525 (15.6) 3929 (19.0)
>45 years 796 (7.3) 452 (4.6) 1248 (6.1)
Blood donor type N (%)
VNRD 4246 (38.9) 1822 (18.7) 6068 (29.4)
FRD 6658 (61.1) 7925 (81.3) 14,583 (70.6)
Occupation N (%)
Healthcare workers 58 (0.5) 89 (0.9) 147 (0.7)
Students 298 (2.7) 2545 (26.1) 2843 (13.8)
Teachers/Researchers 98 (0.9) 206 (2.1) 304 (1.5)
Police and armed forces 1846 (16.9) 1196 (12.3) 3042 (14.7)
Drivers 162 (1.5) 613 (6.3) 775 (3.8)
Government employees 234 (2.1) 437 (4.5) 671 (3.2)
Tailors and Hairdressers 84 (0.8) 282 (2.9) 366 (1.8)
Hotel and restaurant workers 12 (0.1) 54 (0.6) 66 (0.3)
Merchants 24 (0.2) 98 (1.0) 122 (0.6)
Others 8088 (74.2) 4227 (43.4) 12,315 (59.6)
VNRD volunteer non-remunerated donor, FRD Family/Replacement donor
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declined from 8.4% in 2004 to 2.4% in 2016. Previous studies
in Gabon in the 1980s showed higher seroprevalence of
syphilis from 11.4 to 13.3% [9, 10] compared to seropreva-
lence of 4.6 and 2.1% obtained in the 2000s [8, 13]. Compar-
ing data collected in 2004 and 2016 is a limitation of the
study but data from 2005 to 2015 was not available in full
and could not be used reliably. It is possible that part of the
apparent decline in prevalence might be related to improved
assays, or an effect of confirmation that substantially (79%)
decreases the initial reactivity rate of the first test, as shown
in Ghana [5]. The decline in seroprevalence of syphilis ob-
tained in this study is higher than that observed in studies in
Zimbabwe and Morocco among pregnant women attending
antenatal clinics [14] and in Ethiopia where a decline from
2.4 to 0.6% was observed [15].
Syphilis seroprevalence regression of 3.8 to 2% between
2002 and 2011 and 9.8 to 2.8% between 1994 and 2011 were
observed in pregnant women tested with RPR confirmed by
TPHA in Rwanda and Zambia, respectively [16, 17].
The decline we observed is consistent with WHO data
showing a fall from 5.5 to 1.1% in the average seropreva-
lence of syphilis in Central Africa [6]. Decline in sero-
prevalence of syphilis between 2004 and 2016 may be
associated with reduction of sexually transmitted infections
(STIs). Indeed, the dramatic fall in the HIV pandemic in
Gabon may have been accompanied by a decline in syphilis
seroprevalence [18]. From 2008 to 2012, condom use in
Gabon has increased among men (76.5%) and women
(55%) aged 15–24 years [19]. This use has been effective in
preventing HIV and syphilis transmission. In some previous
studies in sub-Saharan Africa, the decline of syphilis has
been associated with the promotion of safer sex among
high-risk groups, the improvement of STI treatment pro-
grams through the use of the syndromic approach, system-
atic screening, self-screening of spouses of positive
screened women [20, 21]. The decline of syphilis seropreva-
lence in our study may also be affected by the urban origin
of the majority of blood donors where intensive campaigns




Characteristics % (n/N) % (n/N) OR (95% CI) P-values
8.4 (912/10904) 2.4 (230/9747) 3.78 (3.26–4.38) <0.001
Gender
Female 6.3 (175/2773) 2.1 (46/2239) 3.21 (2.31–4.46) <0.001
Male 10.0 (737/8131) 2.5 (184/7508) 3.97 (3.37–4.68) <0.001
Age groups (years)
<18 4.7 (6/127) 0/15 NA NA
18–24 4.6 (143/3114) 1.0 (30/3042) 4.83 (3.25–7.19) <0.001
25–35 6.3 (282/4463) 1.7 (80/4713) 3.91 (3.02–5.02) <0.001
36–45 12.5 (301/2404) 5.0 (76/1525) 2.73 (2.10–3.54) <0.001
>45 22.6 (180/796) 9.7 (44/452) 2.71 (1.90–3.86) <0.001
First time donor type
VNRD 8.1 (347/4246) 2.0 (36/1822) 4.42 (3.12–6.25) <0.001
FRD 8.5 (565/6658) 2.5 (194/7925) 3.70 (3.13–4.36) <0.001
Occupation
Healthcare workers 5.2 (3/58) 3.4 (3/89) 1.56 (0.31–8.03) 0.63
Students 5.4 (16/298) 1.2 (31/2545) 4.60 (2.48–8.52) <0.001
Teachers/researchers 9.2 (9/98) 7.3 (15/206) 1.29 (0.54–3.06) 0.73
Police and armed forces 9.1 (168/1846) 1.6 (19/1196) 6.20 (3.84–10.03) <0.001
Drivers 4.9 (8/162) 3.6 (22/613) 1.40 (0.61–3.20) 0.57
Government employees 3.0 (7/234) 2.3 (10/437) 1.32 (0.50–3.51) 0.77
Tailors and hairdressers 0/84 3.6 (10/282) NA NA
Hotel and restaurant workers 0 (0/12) 9.3 (5/54) NA NA
Merchants 8.3 (2/24) 3.1 (3/98) 2.88 (0.45–18.28) 0.25
Others 8.6 (699/8088) 2.7 (112/4227) 3.48 (2.84–4.26) <0.001
VNRD volunteer non-remunerated donor, FRD family/replacement donor, OR Odds ratio, CI Confidence Interval
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against STIs take place; diagnostic tools and quality treat-
ment are available in well-equipped hospital facilities. In-
deed, studies have shown a preponderance of syphilitic
infection in rural areas because of the low level of education
of the populations, limited access to health care and a
higher level of poverty [22, 23].
The seroprevalence of syphilis decreased significantly in
young blood donors between 2004 and 2016. It was higher
among older blood donors, agreeing with the results of an
earlier study in Gabon [11]. Similar results were obtained in
Cameroon by Ankouane et al., [24] and in other studies in
Iran [25] and Israel [26]. The regression of syphilis could be
explained by its low prevalence among predominantly young
blood donors (less than 35 years). The seroprevalence of
syphilis increased with age in both 2004 and 2016, as previ-
ously shown [27]. The highest seroprevalence observed in
the oldest subjects could be explained by a longer exposure
to infection risk; infections may also be the result of past but
healed infections (immunological scars). Some studies, how-
ever, have reported a high prevalence of syphilis in young
people aged 15 to 28 years [16, 28, 29]. The decline in sero-
prevalence of syphilis was similar in both VNRDs and FRDs
and among all socio-professional categories. However, two
previous studies in Zambia and the Democratic Republic of
Congo have associated women’s education level with low
seroprevalence of syphilis [17, 23]. An earlier study in Gabon
reported a seroprevalence of syphilis of 0.73% in a student
population in Libreville [30].
Conclusions
This study has shown that the seroprevalence of syphilis
has decreased in the population of first-time blood do-
nors, which may be a reflection of the adult general
population. However, we have no evidence of how repre-
sentative of the general population the population of
first time blood donors might be. Government actions,
including multiple HIV prevention activities, are a likely
part of this decline.
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